Shuting Bai

2.8k citations
56 papers · 2.3k · 1 hit paper · h-index 23

Impact in

    • Bone Metabolism and Diseases
    • TGF-β signaling in diseases
    • Developmental Biology and Gene Regulation
    • Cancer-related gene regulation

Papers in

    • TGF-β signaling in diseases 6
    • Bone Metabolism and Diseases 5
    • RNA Interference and Gene Delivery 3
    • Immunotherapy and Immune Responses 10

Shuting Bai

51 papers receiving 2.2k citations

Shuting Bai's Hit Papers

Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation 2008 · 528 citations
5280+6+12Years since publication100200300400500

Peers

Shuting Bai
Comparison fields: 5 of 110
  • Otorhinolaryngology 102
  • Molecular Biology 1.2k
  • Cancer Research 214
  • Oncology 384
  • Immunology 276
Replace Hiroyuki Harada with:
Hiroyuki Harada Japan
Torsten E. Reichert Germany
Shigeyuki Murono Japan
Seung Sam Paik South Korea
Qilong Lu United States
Ana M. Schor United Kingdom
Ying‐Tai Jin Taiwan
Daisuke Uchida Japan
Jae Yoon Jung South Korea
Guiquan Zhu China
Shuting Bai relative to Hiroyuki Harada Japan Hiroyuki Harada's profile →
Citations per field
00.5×1.5×2.4×
Hiroyuki Harada · 1×
Citations per year

Countries citing papers authored by Shuting Bai

Since Specialization
Citations

This map shows the geographic impact of Shuting Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuting Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuting Bai more than expected).

Fields of papers citing papers by Shuting Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuting Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuting Bai. The network helps show where Shuting Bai may publish in the future.

Co-authors

The 25 scholars most cited alongside Shuting Bai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shuting Bai Line = papers co-authored together Shuting Bai links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation
Hit paper breakdown →
2008528
2 2007205
3 2002146
4 2012142
5 2000131
6 2003121
7 200292
8 202086
9 200175
10 200648
11 201246
12 201345
13 202142
14 202339
15 200838
16 201535
17 202233
18 202332
19 202127
20 202127

About Shuting Bai

Shuting Bai is a scholar working on Molecular Biology, Immunology, Surgery, Oncology and Genetics, having authored 56 papers that have together received 2.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (10 papers), TGF-β signaling in diseases (6 papers), Bone Metabolism and Diseases (5 papers), Nanoplatforms for cancer theranostics (5 papers), Testicular diseases and treatments (4 papers), Cell Adhesion Molecules Research (4 papers), RNA Interference and Gene Delivery (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Otorhinolaryngology (102 citations), Molecular Biology (1.2k citations), Cancer Research (214 citations), Oncology (384 citations) and Immunology (276 citations). Shuting Bai has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Xu Cao, Xingming Shi, F. Patrick Ross, Steven L. Teitelbaum, Raphael Kopan, Matthew J. Hilton, Fanxin Long, Haibo Zhao, Xiaolin Tu and Tatsuya Kobayashi. Their work appears in journals such as Journal of Controlled Release, Journal of Biological Chemistry, ACS Nano, Acta Pharmaceutica Sinica B and Endocrine Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact